RPG Life Sciences Announcements
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Clarus Capital I
20 Apr, 2026 | 01:04pm • Source: BSE
Certificate in terms of Regulation 74(5) of the SEBI (DP) Regulations, 2018
09 Apr, 2026 | 04:21pm • Source: BSE
Newspaper Advertisement in respect to Special Window opened for lodgment of transfer and dematerialization request(s).
07 Apr, 2026 | 06:29pm • Source: BSE
RPG Life Sciences Limited has informed the Exchange regarding - "Second -100 Days Campaign - Saksham Niveshak"
06 Apr, 2026 | 07:33pm • Source: BSE
Newspaper intimation regarding Special Window for re-lodgement of transfer requests of Physical shares
10 Feb, 2026 | 04:32pm • Source: BSE
Newspaper Publication
28 Jan, 2026 | 03:32pm • Source: BSE
Intimations of Revised Investor presentation
28 Jan, 2026 | 12:02pm • Source: BSE
Investor Presentation in respect to the Board Meeting held on January 27, 2026
27 Jan, 2026 | 08:32pm • Source: BSE
Press Release in respect to the Board Meeting held on January 27, 2026
27 Jan, 2026 | 07:54pm • Source: BSE
Financial Result Quarter ended on December 31, 2025
27 Jan, 2026 | 07:51pm • Source: BSE
Outcome of Board Meeting held on January 27, 2026
27 Jan, 2026 | 07:36pm • Source: BSE
Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018
09 Jan, 2026 | 06:34pm • Source: BSE
Newspaper Publication
07 Jan, 2026 | 07:09pm • Source: BSE
Disclosure under Regulation 30 of SEBI LODR, 2015 for Details of order received from GST Authority, Maharashtra.
29 Dec, 2025 | 04:47pm • Source: BSE
Company has incorporated a Wholly Owned Subsidiary Company in name and style "RPG Active Pharma Limited"
24 Dec, 2025 | 10:09pm • Source: BSE
Closure of Trading window for Quarter and nine months ended on December 31, 2025.
24 Dec, 2025 | 05:06pm • Source: BSE
Disclosure under regulation 30(5) is enclosed
15 Dec, 2025 | 03:41pm • Source: BSE
Intimation with respect to prosed incorporation of a wholly owned subsidiary is enclosed herewith
15 Dec, 2025 | 03:36pm • Source: BSE
intimation on appointment of Mr. Amol Lone as Chief Financial Officer of the Company is enclosed
15 Dec, 2025 | 03:31pm • Source: BSE
Outcome of Board meeting held on December 15, 2025
15 Dec, 2025 | 03:26pm • Source: BSE